Medical News

RSS

High testosterone levels in CEOs linked to higher rate of dropped deals in negotiating M&As

High testosterone levels in CEOs negotiating mergers and acquisitions are linked to a higher rate of dropped deals and an increase in hostile takeover attempts, according to a new study in the current issue of Management Science, a journal of the Institute for Operations Research and the Management Sciences (INFORMS-).

9 Sep 2010

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

Using a newly FDA approved pulmonary valve, Dr. Frank Ing, director of the catheterization laboratory at Texas Children's Hospital and his team of pediatric interventional cardiologists implanted a transcatheter pulmonary heart valve into the heart of a 13-year-old girl, which spared her from having her chest opened for a third heart surgery.

9 Sep 2010

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

EDAP TMS SA, the global leader in therapeutic ultrasound, today reported favorable clinical outcomes for patients treated with Ablatherm-HIFU.

9 Sep 2010

Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children

Nevirapine is widely used to help prevent mother-to-child transmission of the HIV virus. In cases where the infants are nonetheless infected with HIV virus at birth, the standard treatment is to use protease inhibitors (PI) to reduce the amount of virus in their bloodstream. A new study involving 195 infants in South Africa found that children who were treated with PI and then switched to nevirapine were more likely to maintain virus below the detection threshold of the test than infants who continued to receive PI.

9 Sep 2010

Irregular body weight increases mortality risk in women with colon cancer: Study

Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, according to a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

9 Sep 2010

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).

9 Sep 2010

CVS Caremark offers $5 million in free flu shots for uninsured patients

CVS Caremark announced today that it will partner with Direct Relief USA to offer up to $5 million in free flu shots to community clinic and health center patients who lack health insurance.

9 Sep 2010

Insurers raise rates, cancel plans in response to overhaul

The Wall Street Journal: "Aetna Inc., some BlueCross BlueShield plans and other smaller carriers have asked for premium increases of between 1% and 9% to pay for extra benefits required under the law, according to filings with state regulators." The requests undermine "Democrats' efforts to trumpet their signature achievement before the midterm elections."

9 Sep 2010

'Cloud computing improves' speed of analyzing RNA sequencing data

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.

9 Sep 2010

Researchers report massage improves body’s immune response

Researchers in Cedars-Sinai's Department of Psychiatry and Behavioral Neurosciences have reported people who undergo massage experience measureable changes in their body's immune and endocrine response.

9 Sep 2010

$GSK, Genmab commence ofatumumab Phase III study in rituximab refractory patients with indolent B-NHL$

GSK, Genmab commence ofatumumab Phase III study in rituximab refractory patients with indolent B-NHL

GlaxoSmithKline and Genmab A/S announced today the start of a Phase III study in patients with indolent B-cell non-Hodgkin's lymphoma (B-NHL) who did not respond to or progressed during, or within 6 months of a rituximab containing regimen.

9 Sep 2010

Cylene Pharmaceuticals to report recent developments of CX-4945 inhibitor at CK2 International Conference

Cylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.

9 Sep 2010

Health reform myths debunked

The Associated Press examines political ads on health reform. "With the country sharply divided over the sweeping new insurance law, Republicans and their allies are taking to the airwaves to attack it as elections near, often resorting to exaggeration and omissions to make their points."

9 Sep 2010

BioSpace joins Delaware BioScience to launch online career center for life science markets

BioSpace has partnered with the Delaware BioScience Association to launch an online career center for life science markets including pharmaceuticals and biotechnology.

9 Sep 2010

Helicos accuses PacBio of patent infringement, files lawsuit

Helicos BioSciences Corporation announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United States District Court for the District of Delaware, accuses PacBio of infringing four patents and seeks injunctive relief and monetary damages.

9 Sep 2010

Ohio State University receives five-year grant to improve drug therapy using gene profiles

The National Institute of General Medical Sciences has awarded a $9.1 million, five-year grant to The Ohio State University for a study titled "Expression Genetics in Drug Therapy." The goal of the research is to enhance drug response rates and reduce the number of adverse drug reactions among patients taking medication.

9 Sep 2010

Consumer Reports rates heart bypass surgical groups

The New York Times: Consumer Reports will rate groups that perform heart bypass surgery. The group already rates many consumer items like cars and even household appliances. "In most parts of the country, data-based ratings of doctors are not available to patients. Only a few states, including New York, provide them.

9 Sep 2010

Arcapita enters equity investment, option to purchase agreement with St. Jude Medical

Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.

9 Sep 2010

ARID1A gene links ovarian cancer to endometriosis

Researchers with the Ovarian Cancer Research Program of BC (OvCaRe) reveal a major new cancer gene-ARID1A. Mutations are frequent in this gene and link two types of ovarian cancer to endometriosis.

9 Sep 2010

Emergent BioSolutions receives early termination grant to acquire Trubion

Emergent BioSolutions Inc. announced today that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion Pharmaceuticals, Inc. by Emergent BioSolutions announced on August 12, 2010.

9 Sep 2010

Medical News

High testosterone levels in CEOs linked to higher rate of dropped deals in negotiating M&As

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

Switching from protease inhibitors to Nevirapine brings superior results for some HIV-infected children

Irregular body weight increases mortality risk in women with colon cancer: Study

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

CVS Caremark offers $5 million in free flu shots for uninsured patients

Insurers raise rates, cancel plans in response to overhaul

'Cloud computing improves' speed of analyzing RNA sequencing data

Researchers report massage improves body’s immune response

GSK, Genmab commence ofatumumab Phase III study in rituximab refractory patients with indolent B-NHL

Cylene Pharmaceuticals to report recent developments of CX-4945 inhibitor at CK2 International Conference

Health reform myths debunked

BioSpace joins Delaware BioScience to launch online career center for life science markets

Helicos accuses PacBio of patent infringement, files lawsuit

Ohio State University receives five-year grant to improve drug therapy using gene profiles

Consumer Reports rates heart bypass surgical groups

Arcapita enters equity investment, option to purchase agreement with St. Jude Medical

ARID1A gene links ovarian cancer to endometriosis

Emergent BioSolutions receives early termination grant to acquire Trubion

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News